FDA Recalls Cipla Difluprednate Eye Drops for Defective Container Caps
Cipla is recalling 8,136 bottles of Difluprednate ophthalmic emulsion nationwide due to defective container caps that can break and expose the medication tip, compromising sterility.
- Product
- DIFLUPREDNATE — DIFLUPREDNATE (DIFLUPREDNATE)
- Category
- Drug
- Distribution
- Distributed nationwide